Is longitudinal tau PET ready for use in Alzheimer’s disease clinical trials?

Longitudinal tau PET in ageing and Alzheimer’s disease

(2018) Clifford R Jack et al.   BRAIN

Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity

(2017) Sudeepti Southekal et al.   JOURNAL OF NUCLEAR MEDICINE

In vivo retention of 18 F-AV-1451 in corticobasal syndrome

(2017) Ruben Smith et al.   NEUROLOGY

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

(2017) Sebastian Palmqvist et al.   Nature Communications

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology inMAPTmutation carriers

(2016) Ruben Smith et al.   BRAIN

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity

(2013) C. R. Jack et al.   NEUROLOGY

Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease

(2011) Bradley T. Hyman   ARCHIVES OF NEUROLOGY